Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894 · see citing works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · see citing works

Decoding ALS: from genes to mechanism

Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,047 · see citing works

The ubiquitin-proteasome proteolytic pathway

Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804 · see citing works

Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS

Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,079 · see citing works

Non-ATG–initiated translation directed by microsatellite expansions

Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 904 · see citing works

RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention

Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877 · see citing works

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

Zu, T., Liu, Y., Báñez-Coronel, M., Reid, T. S., Pletniková, O., Lewis, J. M., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 748 · see citing works

C9orf72-mediated ALS and FTD: multiple pathways to disease

Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715 · see citing works

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons

Shi, Y., Lin, S., Staats, K. A., Li, Y., Chang, W.-H., Hung, S.-T., Hendricks, E., Linares, G. R., Wang, Y., Son, E. Y., et al. (2018) · Nature Medicine · doi:10.1038/nm.4490 · Cited by 566 · see citing works

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

Lagier‐Tourenne, C., Baughn, M. W., Rigo, F., Sun, S., Liu, P., Li, H., Jiang, J., Watt, A. T., Chun, S. J., Katz, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318835110 · Cited by 555 · see citing works

<i>C9orf72</i> is required for proper macrophage and microglial function in mice

O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550 · see citing works

Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs

Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536 · see citing works

Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins

Mori, K., Arzberger, T., Grässer, F. A., Gijselinck, I., May, S., Rentzsch, K., Weng, S., Schludi, M. H., van der Zee, J., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1189-3 · Cited by 482 · see citing works

Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin‐2 to induce motor neuron dysfunction and cell death

Sellier, C., Campanari, M., Julie Corbier, C., Gaucherot, A., Kolb‐Cheynel, I., Oulad‐Abdelghani, M., Ruffenach, F., Page, A., Ciura, S., Kabashi, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593350 · Cited by 414 · see citing works

C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits

Chew, J., Gendron, T. F., Prudencio, M., Sasaguri, H., Zhang, Y., Castanedes‐Casey, M., Lee, C. W., Jansen‐West, K. R., Kurti, A., Murray, M. E., et al. (2015) · Science · doi:10.1126/science.aaa9344 · Cited by 410 · see citing works

The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy

Webster, C. P., Smith, E. F., Bauer, C. S., Moller, A., Hautbergue, G. M., Ferraiuolo, L., Myszczynska, M. A., Higginbottom, A., Walsh, M. J., Whitworth, A. J., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694401 · Cited by 404 · see citing works

C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD

Liu, Y., Pattamatta, A., Zu, T., Reid, T. S., Bardhi, O., Borchelt, D., Yachnis, A. T., & Ranum, L. P. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.005 · Cited by 368 · see citing works

Neurodegenerative lysosomal disorders: A continuum from development to late age

Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362 · see citing works

Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS

Su, Z., Zhang, Y., Gendron, T. F., Bauer, P. O., Chew, J., Yang, W.-Y., Fostvedt, E., Jansen‐West, K. R., Belzil, V., Desaro, P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.041 · Cited by 358 · see citing works

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345 · see citing works

Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis

Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., & Kabashi, E. (2013) · Annals of Neurology · doi:10.1002/ana.23946 · Cited by 333 · see citing works

The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs

Levine, T. P., Daniels, R. D., Gatta, A. T., Wong, L. H., & Hayes, M. J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts725 · Cited by 321 · see citing works

Gut microbiota in neurodegenerative disorders

Sarkar, S. R., & Banerjee, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.004 · Cited by 319 · see citing works

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood

Belzil, V., Bauer, P., Prudencio, M., Gendron, T. F., Stetler, C. T., Yan, I. K., Pregent, L., Daughrity, L. M., Baker, M., Rademakers, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1199-1 · Cited by 309 · see citing works

The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway

Sullivan, P. M., Zhou, X., Robins, A. M., Paushter, D. H., Kim, D., Smolka, M. B., & Hu, F. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0324-5 · Cited by 295 · see citing works

Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion

Waite, A. J., Bäumer, D., East, S. Z., Neal, J., Morris, H. R., Ansorge, O., & Blake, D. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.016 · Cited by 277 · see citing works

Loss-of-function mutations in the <i>C9ORF72</i> mouse ortholog cause fatal autoimmune disease

Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269 · see citing works

C 9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits

Koppers, M., Blokhuis, A. M., Westeneng, H., Terpstra, M. L., Zundel, C. A. C., de Sá, R. V., Schellevis, R. D., Waite, A. J., Blake, D. J., Veldink, J. H., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24453 · Cited by 268 · see citing works

Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion

Xi, Z., Zinman, L. H., Moreno, D., Schymick, J. C., Liang, Y., Sato, C., Zheng, Y., Ghani, M., Dib, S., Keith, J. L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.017 · Cited by 267 · see citing works

C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice

Atanasio, A., Decman, V., White, D., Ramos, M., Ikiz, B., Lee, H.-C., Siao, C.-J., Brydges, S., LaRosa, E., Bai, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23204 · Cited by 263 · see citing works

Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease

Zhang, D., Iyer, L. M., He, F., & Aravind, L. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00283 · Cited by 244 · see citing works

A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy

Yang, M., Liang, C., Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R., & Chen, J.-F. (2016) · Science Advances · doi:10.1126/sciadv.1601167 · Cited by 238 · see citing works

Cellular toxicity of expanded RNA repeats: focus on RNA foci

Wojciechowska, M., & Krzyżosiak, W. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr299 · Cited by 235 · see citing works

Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1476-2 · Cited by 231 · see citing works

The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease

Haeusler, A. R., Donnelly, C. J., & Rothstein, J. D. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.38 · Cited by 202 · see citing works

Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling

Ugolino, J., Ji, Y. J., Conchina, K., Chu, J., Nirujogi, R. S., Pandey, A., Brady, N. R., Hamacher-Brady, A., & Wang, J. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006443 · Cited by 185 · see citing works

Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans

Therrien, M., Rouleau, G. A., Dion, P. A., & Parker, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083450 · Cited by 183 · see citing works

C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

Liu, E. Y., Russ, J., Wu, K., Neal, D., Suh, E., McNally, A. G., Irwin, D. J., Van Deerlin, V. M., & Lee, E. B. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1286-y · Cited by 180 · see citing works

A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy

Chitiprolu, M., Jagow, C., Tremblay, V., Bondy‐Chorney, E., Paris, G., Savard, A., Palidwor, G., Barry, F. A., Zinman, L. H., Keith, J. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05273-7 · Cited by 179 · see citing works

Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis

Saberi, S., Stauffer, J. E., Jiang, J., Díaz-García, S., Taylor, A. E., Schulte, D. J., Ohkubo, T., Schloffman, C. L., Maldonado, M., Baughn, M. W., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1793-8 · Cited by 178 · see citing works

Enhancing Mitochondrial Calcium Buffering Capacity Reduces Aggregation of Misfolded SOD1 and Motor Neuron Cell Death without Extending Survival in Mouse Models of Inherited Amyotrophic Lateral Sclerosis

Parone, P. A., Cruz, S. D., Han, J. S., McAlonis‐Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 174 · see citing works

The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients

Xi, Z., Zhang, M., Bruni, A. C., Maletta, R., Colao, R., Fratta, P., Polke, J. M., Sweeney, M. G., Mudanohwo, E. E., Nacmias, B., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1401-8 · Cited by 136 · see citing works

Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice

Shao, C., Deng, L., Henegariu, O., Liang, L., Raikwar, N. S., Sahota, A. S., Stambrook, P. J., & Tischfield, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9230 · Cited by 133 · see citing works

Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts

Kramer, N. J., Carlomagno, Y., Zhang, Y., Almeida, S., Cook, C. N., Gendron, T. F., Prudencio, M., van Blitterswijk, M., Belzil, V., Couthouis, J., et al. (2016) · Science · doi:10.1126/science.aaf7791 · Cited by 122 · see citing works

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers

Frick, P., Sellier, C., Mackenzie, I., Cheng, C.-Y., Tahraoui-Bories, J., Martinat, C., Pasterkamp, R., Prudlo, J., Edbauer, D., Oulad-Abdelghani, M., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0579-0 · Cited by 107 · see citing works

Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers

Gendron, T. F., van Blitterswijk, M., Bieniek, K. F., Daughrity, L. M., Jiang, J., Rush, B. K., Pedraza, O., Lucas, J. A., Murray, M. E., Desaro, P., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1474-4 · Cited by 106 · see citing works

GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function

Burguete, A. S., Almeida, S., Gao, F., Kalb, R. G., Akins, M. R., & Bonini, N. M. (2015) · eLife · doi:10.7554/elife.08881 · Cited by 94 · see citing works

Rotarod training in mice is associated with changes in brain structure observable with multimodal MRI

Scholz, J., Niibori, Y., Frankland, P. W., & Lerch, J. P. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.003 · Cited by 92 · see citing works

The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy

Ho, W. Y., Tai, Y. K., Chang, J., Liang, J., Tyan, S.-H., Chen, S., Guan, J., Zhou, H., Shen, H., Koo, E. H., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1569441 · Cited by 70 · see citing works

The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosisPreprint

Zhang, Y., Burberry, A., Wang, J., Sandoe, J., Ghosh, S. D., Udeshi, N. D., Svinkina, T., Mordes, D. A., Mok, J., Charlton, M. E., et al. (2018) · Genes & Development · doi:10.1101/gad.313932.118 · Cited by 69 · see citing works

The Enigmatic Role of C9ORF72 in Autophagy

Nassif, M., Woehlbier, U., & Manque, P. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00442 · Cited by 62 · see citing works

Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment

Jiang, L.-L., Zhu, B., Zhao, Y., Li, X., Liu, T., Piña-Crespo, J., Zhou, L., Xu, W., Gómez-Rodríguez, M. J., Yu, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127695 · Cited by 49 · see citing works

Nuclear pores: the gate to neurodegeneration

Li, N., & Lagier‐Tourenne, C. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0066-0 · Cited by 46 · see citing works

RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention

Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.055 · Cited by 43 · see citing works

Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia

Jiang, J., & Ravits, J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00797-2 · Cited by 42 · see citing works

Autophagy in major human diseases

Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585 · see citing works

30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?

Depienne, C., & Mandel, J.-L. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.011 · Cited by 429 · see citing works

ALS Genetics: Gains, Losses, and Implications for Future Therapies

Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370 · see citing works

Molecular mechanisms underlying nucleotide repeat expansion disorders

Malik, I., Kelley, C. P., Wang, E. T., & Todd, P. K. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00382-6 · Cited by 363 · see citing works

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods

Udayar, V., Chen, Y., Sidransky, E., & Jagasia, R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.004 · Cited by 238 · see citing works

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

Root, J. T., Merino, P., Nuckols, A., Johnson, M. A., & Kukar, T. L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 230 · see citing works

Autophagy and ALS: mechanistic insights and therapeutic implications

Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189 · see citing works

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

Tran, H., Moazami, M. P., Yang, H., McKenna-Yasek, D., Douthwright, C. L., Pinto, C., Metterville, J., Shin, M., Sanil, N., Dooley, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01557-6 · Cited by 174 · see citing works

C9ORF72: What It Is, What It Does, and Why It Matters

Smeyers, J., Banchi, E.-G., & Latouche, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661447 · Cited by 175 · see citing works

The microglial component of amyotrophic lateral sclerosis

Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164 · see citing works

C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly

Wang, T., Liu, H., Itoh, K., Oh, S., Zhao, L., Murata, D., Sesaki, H., Härtung, T., Na, C. H., & Wang, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.005 · Cited by 149 · see citing works

C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation

Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147 · see citing works

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147 · see citing works

Macroautophagy in CNS health and disease

Griffey, C. J., & Yamamoto, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00588-3 · Cited by 144 · see citing works

C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels

Beckers, J., Tharkeshwar, A. K., & Damme, P. V. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 124 · see citing works

The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis

Bampton, A., Gittings, L. M., Fratta, P., Lashley, T., & Gatt, A. P. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02203-0 · Cited by 118 · see citing works

Antisense drugs make sense for neurological diseases

Bennett, C. F., Kordasiewicz, H. B., & Cleveland, D. W. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023738 · Cited by 108 · see citing works

Antisense Oligonucleotides for the Study and Treatment of ALS

Boros, B. D., Schoch, K. M., Kreple, C. J., & Miller, T. M. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01247-2 · Cited by 100 · see citing works

Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies

Li, D., McIntosh, C. S., Mastaglia, F. L., Wilton, S. D., & Aung-Htut, M. T. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00240-7 · Cited by 96 · see citing works

Cellular and physiological functions of C9ORF72 and implications for ALS/FTD

Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 87 · see citing works

Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration

Li, Y., Dou, X., Liu, J., Xiao, Y., Zhang, Z., Hayes, L. R., Wu, R., Fu, X., Ye, Y., Yang, B., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01374-9 · Cited by 82 · see citing works

Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models

Liu, Y., Dodart, J., Tran, H., Berkovitch, S. S., Braun, M. C., Byrne, M., Durbin, A. F., Hu, X. S., Iwamoto, N., Jang, H. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21112-8 · Cited by 81 · see citing works

Gene Therapy in Amyotrophic Lateral Sclerosis

Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., & Ghasemi, M. (2022) · Cells · doi:10.3390/cells11132066 · Cited by 82 · see citing works

TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS

Cunningham, K. M., Maulding, K., Ruan, K., Şentürk, M., Grima, J. C., Sung, H., Zuo, Z., Song, H., Gao, J., Dubey, S. K., et al. (2020) · eLife · doi:10.7554/elife.59419 · Cited by 75 · see citing works

Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis

Cicardi, M. E., Marrone, L., Azzouz, M., & Trotti, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106389 · Cited by 73 · see citing works

CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro

Meijboom, K. E., Abdallah, A., Fordham, N. P., Nagase, H., Rodríguez, T., Kraus, C., Gendron, T. F., Krishnan, G., Esanov, R., Andrade, N. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33332-7 · Cited by 76 · see citing works

NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility

Gleixner, A. M., Verdone, B. M., Otte, C. G., Anderson, E. N., Ramesh, N., Shapiro, O. R., Gale, J. R., Mauna, J. C., Mann, J. R., Copley, K. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31098-6 · Cited by 68 · see citing works

Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 71 · see citing works

Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances

Rizea, R. E., Corlatescu, A.-D., Costin, H. P., Dumitru, A. V., & Ciurea, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189966 · Cited by 76 · see citing works

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?

Trojsi, F., D’Alvano, G., Bonavita, S., & Tedeschi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103647 · Cited by 71 · see citing works

Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish

Butti, Z., Pan, Y. E., Giacomotto, J., & Patten, S. A. (2021) · Communications Biology · doi:10.1038/s42003-021-02302-y · Cited by 69 · see citing works

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD

Schmitz, A., Marques, J. P., Oertig, I., Maharjan, N., & Saxena, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.637548 · Cited by 67 · see citing works

C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?

Braems, E., Swinnen, B., & Bosch, L. V. D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02214-x · Cited by 68 · see citing works

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia

Ranganathan, R., Haque, S., Coley, K., Shepheard, S. R., Cooper‐Knock, J., & Kirby, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00684 · Cited by 59 · see citing works

RNA-mediated toxicity in C9orf72 ALS and FTD

McEachin, Z. T., Parameswaran, J., Raj, N., Bassell, G. J., & Jiang, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105055 · Cited by 57 · see citing works

The sense of antisense therapies in ALS

Daele, S. H. V., Masrori, P., Damme, P. V., & Bosch, L. V. D. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.003 · Cited by 58 · see citing works

Fourth Industrial Revolution

Niaz, S. A., Hameed, W. U., Saleem, M., Bibi, S., Anwer, B., & Razzaq, S. (2020) · Advances in human resources management and organizational development book series · doi:10.4018/978-1-7998-3347-5.ch020 · Cited by 55 · see citing works

Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72 -ALS iPSC-derived microglia contributes to neurodegeneration

Banerjee, P., Mehta, A. R., Nirujogi, R. S., Cooper, J. D., James, O. G., Nanda, J., Longden, J., Burr, K., McDade, K., Salzinger, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq0651 · Cited by 54 · see citing works

Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders

Kim, T., Song, B., & Lee, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144859 · Cited by 55 · see citing works

Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD

Liu, Y., Andreucci, A., Iwamoto, N., Yin, Y., Yang, H., Liu, F., Bulychev, A., Hu, X. S., Lin, X., Lamore, S. D., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.007 · Cited by 52 · see citing works

Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics

Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 52 · see citing works

RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights

Rummens, J., & Cruz, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00851-y · Cited by 52 · see citing works

Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss

Rodriguez, S., Şahin, A., Schrank, B. R., Lawati, H. J. A., Costantino, I. M., Benz, E. G., Fard, D., Albers, A. D., Cao, L., Gomez, A. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4699 · Cited by 53 · see citing works

Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders

Themistokleous, C., Bagnoli, E., Parulekar, R., & Muqit, M. M. K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168144 · Cited by 49 · see citing works

The endolysosomal pathway and ALS/FTD

Todd, T. W., Shao, W., Zhang, Y., & Petrucelli, L. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.09.004 · Cited by 44 · see citing works

All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration

Argueti-Ostrovsky, S., Alfahel, L., Kahn, J., & Israelson, A. (2021) · Cells · doi:10.3390/cells10092438 · Cited by 45 · see citing works

Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation

Liu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01322-x · Cited by 42 · see citing works

Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade

Cantara, S., Simoncelli, G., & Ricci, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094809 · Cited by 42 · see citing works

Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity

Quaegebeur, A., Glaria, I., Lashley, T., & Isaacs, A. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01036-y · Cited by 40 · see citing works

Modelling amyotrophic lateral sclerosis in rodents

Todd, T. W., & Petrucelli, L. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00564-x · Cited by 40 · see citing works

Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD

Odeh, H. M., & Shorter, J. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20190167 · Cited by 38 · see citing works

A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons

Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01648-0 · Cited by 40 · see citing works

The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders

Yang, Q., Jiao, B., & Shen, L. H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.562758 · Cited by 40 · see citing works

Approaches to gene modulation therapy for ALS

Meijboom, K. E., & Brown, R. H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01285-w · Cited by 38 · see citing works

Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges

Zhu, L., Li, S., Li, X., & Yin, P. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00377-7 · Cited by 37 · see citing works

C9orf72-catalyzed GTP loading of Rab39A enables HOPS-mediated membrane tethering and fusion in mammalian autophagy

Zhang, S., Tong, M., Zheng, D., Huang, H., Li, L., Ungermann, C., Pan, Y., Luo, H., Lei, M., Tang, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42003-0 · Cited by 36 · see citing works

Pathological mechanisms of amyotrophic lateral sclerosis

Hu, Y., Chen, W., Wei, C., Jiang, S., Li, S., Wang, X., & Xu, R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382985 · Cited by 36 · see citing works

Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster

Layalle, S., They, L., Ourghani, S., Raoul, C., & Soustelle, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020904 · Cited by 36 · see citing works

An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD

Bauer, C. S., Cohen, R. N., Sironi, F. M., Livesey, M. R., Gillingwater, T. H., Highley, J. R., Fillingham, D. J., Coldicott, I., Smith, E. F., Gibson, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02470-z · Cited by 35 · see citing works

C9orf72 functions in the nucleus to regulate DNA damage repair

He, L., Liang, J., Chen, C.-N., Chen, J., Shen, Y., Sun, S., & Li, L. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01074-0 · Cited by 34 · see citing works

GGC repeat expansion in NOTCH2NLC induces dysfunction in ribosome biogenesis and translation

Fan, Y., Li, M., Yang, H. J., Li, S.-J., Hao, X., Li, J.-D., Wang, Y.-C., Tang, M., Zhang, C., Shi, J., et al. (2023) · Brain · doi:10.1093/brain/awad058 · Cited by 34 · see citing works

Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization

Arogundade, O. A., Nguyen, S., Leung, R., Wainio, D., Gómez-Rodríguez, M. J., & Ravits, J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01125-6 · Cited by 34 · see citing works

CRISPR/Cas9 system and its applications in nervous system diseases

Jiang, H., Tang, M.-Y., Xu, Z., Wang, Y., Li, M., Zheng, S., Zhu, J., Lin, Z., & Zhang, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.017 · Cited by 37 · see citing works

Microglial TREM2 in amyotrophic lateral sclerosis

Xie, M., Zhao, S., Bosco, D. B., Nguyen, A. T., & Wu, L. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22864 · Cited by 34 · see citing works

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit

Sattler, R., Traynor, B. J., Robertson, J., Bosch, L. V. D., Barmada, S. J., Svendsen, C. N., Disney, M. D., Gendron, T. F., Wong, P. C., Turner, M. R., et al. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00548-8 · Cited by 32 · see citing works

Multiple pathways of toxicity induced by C9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model

Frottin, F., Pérez‐Berlanga, M., Hartl, F. U., & Hipp, M. S. (2021) · eLife · doi:10.7554/elife.62718 · Cited by 31 · see citing works

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD

Tang, X., Toro, A., Sahana, T. G., Gao, J., Chalk, J. L., Oskarsson, B., & Zhang, K. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00383-7 · Cited by 32 · see citing works

Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward

Cammack, A. J., Balendra, R., & Isaacs, A. M. (2024) · Brain · doi:10.1093/brain/awae168 · Cited by 31 · see citing works

Structural basis for the ARF GAP activity and specificity of the C9orf72 complex

Su, M.-Y., Fromm, S. A., Remis, J. P., Toso, D. B., & Hurley, J. H. (2021) · Nature Communications · doi:10.1038/s41467-021-24081-0 · Cited by 29 · see citing works

C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation

Licata, N. V., Cristofani, R., Salomonsson, S. E., Wilson, K. M., Kempthorne, L., Vaizoglu, D., D’Agostino, V., Pollini, D., Loffredo, R., Pancher, M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105026 · Cited by 29 · see citing works

Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology

Diab, R., Pilotto, F., & Saxena, S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1086895 · Cited by 31 · see citing works

C9orf72 hexanucleotide repeat expansions impair microglial response in ALS

Masrori, P., Bijnens, B., Fumagalli, L., Davie, K., Poovathingal, S. K., Meese, T. S., Storm, A., Hersmus, N., Fazal, R., van den Biggelaar, D., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02075-1 · Cited by 30 · see citing works

Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD

Solomon, D. A., Smikle, R., Reid, M. J., & Mizielinska, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.664151 · Cited by 30 · see citing works

Dorsomedial prefrontal hypoexcitability underlies lost empathy in frontotemporal dementia

Phillips, H. L., Dai, H., Choi, S. Y., Jansen‐West, K. R., Zajicek, A. S., Daly, L., Petrucelli, L., Gao, F., & Yao, W. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.027 · Cited by 29 · see citing works

Microglia in ALS: Insights into Mechanisms and Therapeutic Potential

Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 32 · see citing works

Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo

Kempthorne, L., Vaizoglu, D., Cammack, A. J., Carcolé, M., Roberts, M. J., Mikheenko, A., Fisher, A., Suklai, P., Muralidharan, B., Kroll, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55550-x · Cited by 27 · see citing works

Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granules

McGoldrick, P., Lau, A., You, Z., Durcan, T. M., & Robertson, J. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112134 · Cited by 26 · see citing works

Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave

Arnold, F. J., Nguyen, A., Bedlack, R., Bennett, C. L., & Spada, A. R. L. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106218 · Cited by 26 · see citing works

Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies

Gittings, L. M., & Sattler, R. (2020) · Faculty Reviews · doi:10.12703/b/9-12 · Cited by 26 · see citing works

A mouse model with widespread expression of the C9orf72-linked glycine–arginine dipeptide displays non-lethal ALS/FTD-like phenotypes

Verdone, B. M., Cicardi, M. E., Wen, X., Sriramoji, S., Russell, K. A., Markandaiah, S. S., Jensen, B. K., Krishnamurthy, K., Haeusler, A. R., Pasinelli, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09593-z · Cited by 23 · see citing works

Biomolecular condensates and disease pathogenesis

Ruan, K., Bai, G., Fang, Y., Li, D., Li, T., Liu, X., Lu, B., Lü, Q., Songyang, Z., Sun, S., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2661-3 · Cited by 27 · see citing works

TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies

Ho, P., Hsieh, T., & Tsai, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102441 · Cited by 25 · see citing works

Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects

de Calbiac, H., Renault, S., Haouy, G., Jung, V. A., Roger, K., Zhou, Q., Campanari, M., Chentout, L., Demy, D. L., Marian, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2358736 · Cited by 23 · see citing works

RAB39B's role in membrane traffic, autophagy, and associated neuropathology

Tang, B. L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29962 · Cited by 25 · see citing works

RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3

Ramesh, N., Daley, E. L., Gleixner, A. M., Mann, J. R., Kour, S., Mawrie, D., Anderson, E. N., Kofler, J., Donnelly, C. J., Kiskinis, E., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01060-y · Cited by 25 · see citing works

Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2α-dependent ISR in C9ORF72 FTD/ALS

Parameswaran, J., Zhang, N., Braems, E., Tilahun, K., Pant, D. C., Yin, K., Asress, S., Heeren, K., Banerjee, A., Davis, E., et al. (2023) · eLife · doi:10.7554/elife.85902 · Cited by 25 · see citing works

The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS

Kawabe, Y., Mori, K., Yamashita, T., Gotoh, S., & Ikeda, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019102700 · Cited by 24 · see citing works

Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis

Ho, W. Y., Navakkode, S., Liu, F., Soong, T. W., & Ling, S. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01030-4 · Cited by 24 · see citing works

Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis

Nguyen, L. (2024) · Cells · doi:10.3390/cells13110888 · Cited by 24 · see citing works

Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases

Jiang, L., Zhang, X.-L., & Hu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212380 · Cited by 24 · see citing works

The porphyrin TMPyP4 inhibits elongation during the noncanonical translation of the FTLD/ALS-associated GGGGCC repeat in the C9orf72 gene

Mori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 22 · see citing works

Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis

Neel, D. V., Basu, H., Gunner, G., & Chiu, I. M. (2022) · Immunological Reviews · doi:10.1111/imr.13083 · Cited by 22 · see citing works

DNA-initiated Epigenetic Cascades Driven by C9orf72 Hexanucleotide Repeat

Liu, Y., Huang, Z.-Y., Liu, H., Ji, Z.-C., Arora, A., Cai, D., Wang, H., Liu, M., Simko, E. A. J., Zhang, Y., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.022 · Cited by 20 · see citing works

RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies

Guo, S., Nguyen, L., & Ranum, L. P. W. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.11.001 · Cited by 22 · see citing works

Blocking RAN translation without altering repeat RNAs rescues C9ORF72 -related ALS and FTD phenotypes

Jiang, X., Schaeffer, L., Patni, D., Russo, T., Lee, C.-Z., Aguilar, C., Marques, C., Jansen‐West, K. R., Hruška-Plocháň, M., Ray-Soni, A., et al. (2026) · Science · doi:10.1126/science.adv2600 · Cited by 22 · see citing works

Frontotemporal Dementia and Glucose Metabolism

Garrett, L. R., & Niccoli, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.812222 · Cited by 20 · see citing works

Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS

McGoldrick, P., & Robertson, J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1247297 · Cited by 20 · see citing works

Nucleoporins are degraded via upregulation of ESCRT-III/Vps4 complex in Drosophila models of C9-ALS/FTD

Dubey, S. K., Maulding, K., Sung, H., & Lloyd, T. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111379 · Cited by 20 · see citing works

FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD

Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338 · Cited by 20 · see citing works

Molecular mechanisms and therapeutic strategies for neuromuscular diseases

Zambon, A. A., Falzone, Y. M., Bolino, A., & Previtali, S. C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05229-9 · Cited by 20 · see citing works

Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders

Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N. (2020) · The EMBO Journal · doi:10.15252/embj.2018100574 · Cited by 137 · see citing works

Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia

Stepto, A., Gallo, J., Shaw, C. E., & Hirth, F. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1235-1 · Cited by 51 · see citing works

Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs

Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536 · see citing works

Realizing the gains and losses in C9ORF72 ALS/FTD

Lutz, C. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0622-x · Cited by 6 · see citing works

Characterization of C9orf72 function in autophagy and RNA metabolism

Nörpel, J. (2022) · edoc (University of Basel) · doi:10.5451/unibas-ep90880